North America Digital Therapeutics Market: Industry Analysis and Market Forecast (2017-2024) -by Sales Channel, by Application, and by Geography

North America Digital Therapeutics Market: Industry Analysis and Market Forecast (2017-2024) -by Sales Channel, by Application, and by Geography

Market Scenario

North America Digital Therapeutics Market is expected to reach US$ 7,833 Mn by 2024 from US$ 1,751 Mn in 2016 at CAGR of 20.5% during a forecast period.North America Digital Therapeutics Market North America Digital Therapeutics market is segmented by Sales channel, By Application & by Geography. The sales channel is classified into B2B & B2C. By application, a market is divided into Preventive Applications, Treatment/Care-Related Applications. Digital therapeutics, commonly known as software for drugs has been increasing much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient’s vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important drivers offered by digital therapeutics. Rising in internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention. On the basis of sale channel. Sales channel segment is bifurcated as B2B and B2C. B2B segment is expected to lead the market growth. This growth is attributed to the rising adoption of digital therapeutics in this segment, especially among payers and employers. Based on application, the Preventive application segment is expected to dominate the market growth owing to, increasing government initiatives to increase the focus on preventive healthcare and a rising consensus among policymakers. North America is one of the major markets for Digital Therapeutics globally where U.S. and Canada are the two major regions profiled under this report. The U.S. has been reported to spend USD 3.2 trillion a year on healthcare. In order to control this expense, there is a rising focus on preventive healthcare, to indorse overall patient wellness as an alternative to medical treatment. Key players operate on the market are, Evolent Health, Inc., Pear Therapeutics, Inc. WellDoc Inc. Nanobiosym, Inc., Twine Health, Inc.,Mango Health Inc., Canary Health Inc., 2morrow Inc., Propeller Health, Ginger.Io, Inc., Noom Inc., Livongo Health, Omada Health, Inc., Proteus Digital Health, Inc.

The Scope of the North America Digital Therapeutics Market

North America Digital Therapeutics market, By Sale channel

• B2B • B2C

North America Digital Therapeutics Market, By Application

• Preventive Applications • Treatment/Care-Related Applications

North America Digital Therapeutics Market, By Region

• North America • U.S. • Canada

Key Players operating in the North America Digital Therapeutics market

• Evolent Health, Inc. • Pear Therapeutics, Inc. • WellDoc Inc. • Nanobiosym, Inc. • Twine Health, Inc. • Mango Health Inc. • Canary Health Inc. • 2morrow Inc. • Propeller Health • Ginger.Io, Inc. • Noom Inc. • Livongo Health • Omada Health, Inc. • Proteus Digital Health, Inc. Global Digital Therapeutics Market

Table of Contents

North America Digital Therapeutics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. North America Digital Therapeutics Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. North America Digital Therapeutics Market Analysis and Forecast 5.1. North America Digital Therapeutics Market Analysis and Forecast 5.2. North America Digital Therapeutics Market Size& Y-o-Y Growth Analysis 5.2.1. North America 6. North America Digital Therapeutics Market Analysis and Forecast, by Sale Channel 6.1. Introduction and Definition 6.2. Key Findings 6.3. North America Digital Therapeutics Market Value Share Analysis, by Sale Channel 6.4. Market Size (US$ Mn) Forecast, by Sale Channel 6.5. Digital Therapeutics Market Analysis, by Sale Channel 6.6. North America Digital Therapeutics Market Attractiveness Analysis, by Sale Channel 7. North America Digital Therapeutics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. North America Digital Therapeutics Market Value Share Analysis, by Application 7.3. Market Size (US$ Mn) Forecast, by Application 7.4. North America Digital Therapeutics Market Analysis, by Application 7.5. North America Digital Therapeutics Market Attractiveness Analysis, by Application 8. North America Digital Therapeutics Market Analysis, by Region 8.1. North America Digital Therapeutics Market Value Share Analysis, by Region 8.2. Market Size (US$ Mn) Forecast, by Region 8.3. North America Digital Therapeutics Market Attractiveness Analysis, by Region 9. North America Digital Therapeutics Market Analysis 9.1. Key Findings 9.2. North America Digital Therapeutics Market Overview 9.3. North America Digital Therapeutics Market Value Share Analysis, by Sale Channel 9.4. North America Digital Therapeutics Market Forecast, by Sale Channel 9.4.1. B2B 9.4.2. B2C 9.5. North America Digital Therapeutics Market Value Share Analysis, by Application 9.6. North America Digital Therapeutics Market Forecast, by Application 9.6.1. Preventive Applications 9.6.2. Treatment/Care-Related Applications 9.7. North America Digital Therapeutics Market Value Share Analysis, by Country 9.8. North America Digital Therapeutics Market Forecast, by Country 9.8.1. U.S 9.8.2. Canada 9.8.3. Rest of North America 9.9. North America Digital Therapeutics Market Analysis, by Country/ Sub-region 9.10. U.S Digital Therapeutics Market Forecast, by Sale Channel 9.10.1. B2B 9.10.2. B2C 9.11. U.S Digital Therapeutics Market Forecast, by Application 9.11.1. Preventive Applications 9.11.2. Treatment/Care-Related Applications 9.12. Canada Digital Therapeutics Market Forecast, by Sale Channel 9.12.1. B2B 9.12.2. B2C 9.13. Canada Digital Therapeutics Market Forecast, by Application 9.13.1. Preventive Applications 9.13.2. Treatment/Care-Related Applications 9.14. Rest of North America Digital Therapeutics Market Forecast, by Sale Channel 9.14.1. B2B 9.14.2. B2C 9.15. Rest of North America Digital Therapeutics Market Forecast, by Application 9.15.1. Preventive Applications 9.15.2. Treatment/Care-Related Applications 9.16. North America Digital Therapeutics Market Attractiveness Analysis 9.16.1. By Sale Channel 9.16.2. By Application 9.16.3. By Business Function 9.17. PEST Analysis 10. Company Profiles 10.1. Market Share Analysis, by Company 10.2. Competition Matrix 10.3. Company Profiles: Key Players 10.3.1. Evolent Health, Inc. 10.3.1.1. Company Overview 10.3.1.2. Financial Overview 10.3.1.3. Business Strategy 10.3.1.4. Recent Developments 10.3.1.5. Stock Management Footprint 10.3.2. Evolent Health, Inc. 10.3.3. Pear Therapeutics, Inc. 10.3.4. WellDoc Inc. 10.3.5. Nanobiosym, Inc. 10.3.6. Twine Health, Inc. 10.3.7. Mango Health Inc. 10.3.8. Canary Health Inc. 10.3.9. 2morrow Inc. 10.3.10. Propeller Health 10.3.11. Ginger.Io, Inc. 10.3.12. Noom Inc. 10.3.13. Livongo Health 10.3.14. Omada Health, Inc. 10.3.15. Proteus Digital Health, Inc. 11. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID7077
Category Information Technology & Telecommunication
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now